Poly Medicure 관리
관리 기준 확인 2/4
Poly Medicure CEO는 Himanshu Baid, Sep1995 에 임명되었습니다 의 임기는 29.17 년입니다. 총 연간 보상은 ₹ 171.78M, 33.6% 로 구성됩니다. 33.6% 급여 및 66.4% 보너스(회사 주식 및 옵션 포함). 는 ₹ 30.58B 가치에 해당하는 회사 주식의 11.59% 직접 소유합니다. 30.58B. 경영진과 이사회의 평균 재임 기간은 각각 6.4 년과 8.4 년입니다.
주요 정보
Himanshu Baid
최고 경영자
₹171.8m
총 보상
| CEO 급여 비율 | 33.6% |
| CEO 임기 | 29.2yrs |
| CEO 소유권 | 11.6% |
| 경영진 평균 재임 기간 | 6.4yrs |
| 이사회 평균 재임 기간 | 8.4yrs |
최근 관리 업데이트
Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 20
Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 22Recent updates
Why Investors Shouldn't Be Surprised By Poly Medicure Limited's (NSE:POLYMED) 33% Share Price Surge
Nov 02Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 20Poly Medicure (NSE:POLYMED) Will Pay A Dividend Of ₹3.00
Sep 14After Leaping 41% Poly Medicure Limited (NSE:POLYMED) Shares Are Not Flying Under The Radar
Sep 06Poly Medicure (NSE:POLYMED) Has A Pretty Healthy Balance Sheet
Aug 14Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹2,138
Jul 27Investors Still Waiting For A Pull Back In Poly Medicure Limited (NSE:POLYMED)
Jul 11Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations
May 25Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital
May 12Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up
Mar 23Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today
Feb 15Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 16Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?
Nov 14Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward
Oct 24Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 22Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Aug 12Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching
Jul 13Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return
Jun 16Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital
Mar 02We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Feb 14Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal
Oct 16We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Sep 28Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Jun 25A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)
Jun 07Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends
May 23With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Feb 23There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital
Feb 04Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 12With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Oct 14Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt
Jul 07Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends
Jun 18Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals
May 31Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195
May 26CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹3b |
| Jun 30 2024 | n/a | n/a | ₹3b |
| Mar 31 2024 | ₹172m | ₹58m | ₹3b |
| Dec 31 2023 | n/a | n/a | ₹2b |
| Sep 30 2023 | n/a | n/a | ₹2b |
| Jun 30 2023 | n/a | n/a | ₹2b |
| Mar 31 2023 | ₹130m | ₹55m | ₹2b |
| Dec 31 2022 | n/a | n/a | ₹2b |
| Sep 30 2022 | n/a | n/a | ₹1b |
| Jun 30 2022 | n/a | n/a | ₹1b |
| Mar 31 2022 | ₹107m | ₹49m | ₹1b |
| Dec 31 2021 | n/a | n/a | ₹1b |
| Sep 30 2021 | n/a | n/a | ₹1b |
| Jun 30 2021 | n/a | n/a | ₹1b |
| Mar 31 2021 | ₹92m | ₹44m | ₹1b |
| Dec 31 2020 | n/a | n/a | ₹1b |
| Sep 30 2020 | n/a | n/a | ₹1b |
| Jun 30 2020 | n/a | n/a | ₹1b |
| Mar 31 2020 | ₹62m | ₹35m | ₹959m |
| Dec 31 2019 | n/a | n/a | ₹947m |
| Sep 30 2019 | n/a | n/a | ₹858m |
| Jun 30 2019 | n/a | n/a | ₹719m |
| Mar 31 2019 | ₹44m | ₹14m | ₹654m |
| Mar 31 2018 | ₹41m | ₹14m | ₹706m |
보상 대 시장: Himanshu 의 총 보상 ($USD 2.03M )은 Indian 시장( $USD 618.18K ).
보상과 수익: Himanshu 의 보상은 지난 1년 동안 20% 이상 증가했습니다.
CEO
Himanshu Baid (56 yo)
29.2yrs
테뉴어
₹171,781,000
보상
Mr. Himanshu Baid has been the Managing Director of Poly Medicure Limited since September 20, 1995 and serves as Chief Executive Officer. Mr. Baid is an Electronics Engineer and has experience in respect t...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO, MD & Director | 29.2yrs | ₹171.78m | 11.59% ₹ 30.6b | |
| Founder & Non Executive Director | no data | ₹1.43m | 2.25% ₹ 5.9b | |
| Chief Financial Officer | 3.3yrs | ₹11.21m | 데이터 없음 | |
| Company Secretary & Compliance Officer | 9.5yrs | ₹1.88m | 데이터 없음 | |
| Joint MD & Executive Director | no data | ₹166.82m | 12.38% ₹ 32.7b | |
| President of Corporate Sales & Marketing | 2.6yrs | ₹18.39m | 1.66% ₹ 4.4b | |
| Assistant Vice President of Finance & Accounts | no data | 데이터 없음 | 데이터 없음 | |
| Senior Vice President of Domestic Sales & Marketing | no data | ₹5.79m | 데이터 없음 | |
| President of R&D | no data | ₹5.61m | 데이터 없음 | |
| President of Sales & Marketing - India | no data | ₹8.61m | 데이터 없음 |
6.4yrs
평균 재임 기간
56yo
평균 연령
경험이 풍부한 관리: POLYMED 의 관리팀은 노련하고 경험 (평균 재직 기간 6.4 년)입니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO, MD & Director | 29.7yrs | ₹171.78m | 11.59% ₹ 30.6b | |
| Founder & Non Executive Director | 29.7yrs | ₹1.43m | 2.25% ₹ 5.9b | |
| Joint MD & Executive Director | 29.7yrs | ₹166.82m | 12.38% ₹ 32.7b | |
| Non-Executive Independent Director | less than a year | 데이터 없음 | 데이터 없음 | |
| Non-Executive Independent Director | 4.4yrs | ₹1.60m | 데이터 없음 | |
| Non-Executive Independent Chairman | 19.5yrs | ₹1.63m | 데이터 없음 | |
| Non-Executive Director | 10.3yrs | ₹1.43m | 3.02% ₹ 8.0b | |
| Non-Executive Independent Director | 4.3yrs | ₹1.45m | 데이터 없음 | |
| Non-Executive Non Independent Director | 6.5yrs | ₹29.90m | 데이터 없음 | |
| Independent Director | 2.6yrs | ₹1.45m | 데이터 없음 |
8.4yrs
평균 재임 기간
64.5yo
평균 연령
경험이 풍부한 이사회: POLYMED 의 이사회는 경험(평균 재직 기간 8.4 년)으로 간주됩니다.